Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Pediatr Allergy Immunol ; 27(2): 177-84, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26592211

ABSTRACT

BACKGROUND: Hyper-IgE syndromes (HIES) are primary immunodeficiency disorders characterized by elevated serum IgE, eczema, and recurrent infections. Despite the availability of confirmatory molecular diagnosis of several distinct HIES entities, the differentiation of HIES particularly from severe forms of atopic dermatitis remains a challenge. The two most common forms of HIES are caused by mutations in the genes STAT3 and DOCK8. METHODS: Here, we assess the clinical and immunologic phenotype of DOCK8- and STAT3-HIES patients including the cell activation, proliferation, and cytokine release after stimulation. RESULTS: Existing HIES scoring systems are helpful to identify HIES patients. However, those scores may fail in infants and young children due to the age-related lack of clinical symptoms. Furthermore, our long-term observations showed a striking variation of laboratory results over time in the individual patient. Reduced memory B-cell counts in concert with low specific antibody production are the most consistent findings likely contributing to the high susceptibility to bacterial and fungal infection. In DOCK8-HIES, T-cell lymphopenia and low IFN-gamma secretion after stimulation were common, likely promoting viral infections. In contrast to STAT3-HIES, DOCK8-HIES patients showed more severe inflammation with regard to allergic manifestations, elevated activation markers (HLA-DR, CD69, CD86, and CD154), and significantly increased inflammatory cytokines (IL1-beta, IL4, IL6, and IFN-gamma). CONCLUSION: Differentiating HIES from other diseases such as atopic dermatitis early in life is essential for patients because treatment modalities differ. To expedite the diagnosis process, we propose here a diagnostic workflow.


Subject(s)
Dermatitis, Atopic/diagnosis , Guanine Nucleotide Exchange Factors/genetics , Job Syndrome/diagnosis , Mutation/genetics , STAT3 Transcription Factor/genetics , B-Lymphocytes/immunology , Cells, Cultured , Child, Preschool , Cytokines/metabolism , Diagnosis, Differential , Female , Humans , Immunoglobulin E/blood , Immunologic Memory , Infant , Job Syndrome/genetics , Lymphocyte Activation/genetics , Male , T-Lymphocytes/immunology
2.
J Clin Immunol ; 33(5): 896-902, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23584561

ABSTRACT

PURPOSE: Autosomal dominant hyper-IgE syndrome (AD-HIES) due to heterozygous STAT3 mutation is a primary immunodeficiency characterized by eczema, elevated serum IgE, recurrent infections, and connective tissue and skeletal findings. Healing of pneumonias is often abnormal with formation of pneumatoceles and bronchiectasis. We aimed to explore whether healing after lung surgery is also aberrant. METHODS: We retrospectively analyzed the medical records of 32 patients with AD-HIES who received lung surgery for the management of pulmonary infections from 1960 to 2011. We collected information including patient demographics, STAT3 mutation status, clinical history, surgical and medical procedures performed, complications, related medical treatments, and outcomes. RESULTS: More than 50% of lung surgeries had associated complications, with the majority being prolonged bronchopleural fistulae. These fistulae often led to empyemas that necessitated additional interventions including prolonged antibiotics, prolonged thoracostomy tube drainage and re-operations. CONCLUSION: Lung surgery in AD-HIES patients is associated with high complication rates. STAT3 mutations likely lead to abnormalities in tissue remodelling that are further exacerbated by infection.


Subject(s)
Job Syndrome/immunology , Job Syndrome/physiopathology , Lung Diseases/physiopathology , Lung Diseases/surgery , Wound Healing/physiology , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Lung/immunology , Lung/physiopathology , Lung/surgery , Lung Diseases/genetics , Lung Diseases/immunology , Male , Middle Aged , Mutation , Retrospective Studies , STAT3 Transcription Factor/genetics , Wound Healing/genetics , Young Adult
3.
J Clin Immunol ; 32(6): 1404-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22843217

ABSTRACT

Helicobacter bilis, an unusual cause of chronic infections in patients with X-linked agammaglobulinemia (XLA), is notoriously difficult to diagnose and eradicate. Based on the limited number of cases reported worldwide, we highlight the typical features of H. bilis infection in XLA and provide a rational and successful approach to diagnosis and treatment of this challenging infection.


Subject(s)
Agammaglobulinemia/drug therapy , Anti-Bacterial Agents/therapeutic use , Azithromycin/therapeutic use , Genetic Diseases, X-Linked/drug therapy , Helicobacter Infections/drug therapy , Helicobacter/drug effects , Ofloxacin/therapeutic use , beta-Lactams/therapeutic use , Adolescent , Adult , Agammaglobulinemia/complications , Agammaglobulinemia/diagnosis , Agammaglobulinemia/pathology , Chronic Disease , Ertapenem , Genetic Diseases, X-Linked/complications , Genetic Diseases, X-Linked/diagnosis , Genetic Diseases, X-Linked/pathology , Helicobacter/genetics , Helicobacter/pathogenicity , Helicobacter Infections/complications , Helicobacter Infections/diagnosis , Helicobacter Infections/pathology , Humans , Male , Phylogeny , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...